Staar Surgical EV/EBIT STAA

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2012.

Today, Oct 23, 2026: 57.7×
8-year median: 92.1×
Against its 8-year history: 14th; percentile: 0 is its lowest day, 100 its highest
8-year range: 21.7× to 477×
Peer median: 24.1×

Staar Surgical's EV/EBIT is 57.7× as of Oct 23, 2026.

That is below its 8-year median of 92.1×, lower than on 86% of days in the last 8 years.

Over that time it ranged from 21.7× in Feb 2025 to 477× in Nov 2018.

The median for 10 medical instruments and supplies stocks of a similar size is 24.1×.

EV/EBIT over time

median 92.1×

The dashed line is the 8-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	57.7×	51.5×	68.1×
2025	24.6×	21.7×	39.2×
2024	38.6×	38.6×	91.9×
2023	73.5×	54.0×	89.4×
2022	43.0×	42.8×	125×
2021	139×	136×	456×
2020	276×	89.7×	292×
2019	143×	117×	364×
2018	309×	293×	477×
2017	n/m a value too high to mean anything
2016	n/m a value too high to mean anything
2015	n/m a value too high to mean anything
2014	180×	150×	239×
2013	171×	64.6×	171×
2012	72.4×	60.7×	129×

Against its peers

Companies in Medical - Instruments & Supplies nearest Staar Surgical's size, closest first, today.

Company	EV/EBIT
STAAStaar Surgical	57.7×
IRMDIradimed	37.7×
BVSBioventus	26.2×
CDRECadre	23.2×
EYENational Vision	19.2×
MOVMovado	11.8×
LMATLemaitre Vascular	22.6×
INSPInspire Medical Systems	32.6×
MDXGMimedx	51.6×
UFPTUFP Technologies	24.9×
TCMDTactile Systems Technology	13.3×
Peer median	24.1×

Where Staar Surgical ranks

#41of 46Medical instruments and supplies stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Staar Surgical

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.